metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Vascular Risk Factors and Cognitive Performance in Patients 50 to 65 Years-Old
Journal Information
Vol. 25. Issue 7.
Pages 422-429 (January 2010)
Share
Share
Download PDF
More article options
Vol. 25. Issue 7.
Pages 422-429 (January 2010)
Original article
Full text access
Vascular Risk Factors and Cognitive Performance in Patients 50 to 65 Years-Old
Factores de riesgo vascular y rendimiento cognitivo en personas de 50 a 65 años
Visits
1423
J. Miralbella, J.J. Sorianoa, E. López-Canciob, J.F. Arenillasc, L. Doradob, M. Barriosd, C. Cáceresb, M.T. Alzamorae, P. Toráne, G. Perae, A. Dávalosb, M. Mataróa,f,
Corresponding author
mmataro@ub.edu

Corresponding author.
a Departamento de Psiquiatría y Psicobiología Clínica, Universidad de Barcelona, Barcelona, Spain
b Departamento de Neurociencias, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
c Servicio de Neurología, Unidad de Ictus, Hospital Clínico Universitario, Valladolid, Spain
d Departamento de Metodología y Ciencias del Comportamiento, Universidad de Barcelona, Barcelona, Spain
e Centro de Investigación Barcelonès Nord Maresme, ICS-IDIAP Jordi Gol, Mataró, Barcelona, Spain
f Instituto de Investigación Cerebro, Cognición y Conducta, IR3C, Barcelona, Spain
This item has received
Article information
Abstract
Introduction

Vascular risk factors (VRF) have been related to cognitive deficits and an increased risk of dementia. Cognitive impairment is considered to be one of the earliest manifestations of cerebrovascular disease. In Spain there is a high prevalence of VRF, but also one of the lowest incidences of cerebrovascular disease in Europe. This is the first study that investigates the relationship between VRF and cognition in a Spanish sample.

Methods

A total of 90 people aged between 50–65 years with a low-to-moderate cardiovascular risk underwent a neuropsychological evaluation. None of them had a history of cardiovascular disease. The battery included tests assessing executive, attentional, mnesic, visuospatial and motor-speed/coordination functions. We used correlation and inter-groups comparison to relate VRF to multiple cognitive domains24.

Results

Higher stroke risk was significantly related to a lowered profile in visuo-constructive functions and motor-speed/coordination. Moreover, the group with moderate cardiovascular risk showed a lower performance in visuoconstructive functions compared to the low-risk group. After statistical adjustment for age, sex and years of scholarship VRF were only related to motor-speed/coordination.

Conclusions

In healthy, middle-aged adults, VRF are related with impairment in two cognitive domains. This effect is slight and tends to appear in people with moderate cardiovascular risk.

Keywords:
Cognition
Barcelona-ASIA Study
Risk factor
Stroke
Neuropsychology
Mediterranean paradox
Resumen
Introducción

Los factores de riesgo vascular (FRV) se han relacionado con déficit cognitivos e incremento del riesgo de demencia. De hecho, el deterioro cognitivo es considerado como una de las primeras manifestaciones de enfermedad cerebrovascular. En nuestro país se ha registrado una elevada prevalencia de FRV junto a una incidencia de ictus de las más bajas de Europa. Éste es el primer estudio con población española que investiga la relación entre los FRV y el rendimiento cognitivo en la edad adulta.

Métodos

Se ha realizado evaluación neuropsicológica a 90 personas de 50–65 años de edad con riesgo cardiovascular bajo, leve y moderado, sin historia de enfermedad cardiovascular. Se les administró una batería de test sensible a funciones ejecutivas, atencionales, mnésicas, visuoconstructivas y de velocidad/coordinación visuomotriz. Se han hecho análisis de correlación y comparación entre grupos para estudiar la relación entre los FRV y las diferentes funciones cognitivas.

Resultados

Se observó una relación estadísticamente significativa entre un mayor riesgo vascular y un peor rendimiento en funciones visuoconstructivas y en velocidad/coordinación visuomotriz. Además, el grupo de riesgo moderado presentó un rendimiento significativamente inferior respecto al de riesgo bajo en funciones visuoconstructivas. Tras covariar por edad, sexo y años de escolaridad los FRV únicamente se relacionaron con velocidad/coordinación visuomotriz.

Conclusiones

Los FRV en personas de mediana edad están relacionados con disminución del rendimiento en dos funciones cognitivas. La afectación es leve y tiende a evidenciarse en personas con un riesgo moderado.

Palabras clave:
Cognición
Estudio Barcelona-ASIA
Factores de riesgo
Ictus
Neuropsicología
Paradoja mediterránea
Full text is only aviable in PDF
References
[1.]
V. Hachinski, C. Iadecola, R.C. Petersen, M.M. Breteler, D.L. Nyenhuis, S.E. Black, et al.
National institute of neurological disorders and stroke-canadian stroke network vascular cognitive impairment harmonization standards.
[2.]
V. Hachinski.
The 2005 thomas willis lecture: Stroke and vascular cognitive impairment: A transdisciplinary, translational and transactional approach.
[3.]
L.B. Goldstein, R. Adams, M.J. Alberts, L.J. Appel, L.M. Brass, C.D. Bushnell, et al.
Primary prevention of ischemic stroke: A guideline from the american heart Association/American stroke association stroke council: Cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group.
Circulation, 113 (2006), pp. e873-e923
[4.]
M.F. Elias, L.M. Sullivan, R.B. D’Agostino, P.K. Elias, A. Beiser, R. Au, et al.
Framingham stroke risk profile and lowered cognitive performance.
[5.]
D.J. Llewellyn, I.A. Lang, J. Xie, F.A. Huppert, D. Melzer, K.M. Langa.
Framingham stroke risk profile and poor cognitive function: A population-based study.
BMC Neurol, 8 (2008), pp. 12
[6.]
B. Segura, M.A. Jurado.
Metabolic syndrome and ageing: Cognitive impairment and structural alterations of the central nervous system.
Rev Neurol, 49 (2009), pp. 417-424
[7.]
M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt, B. Winblad, et al.
Obesity and vascular risk factors at midlife and the risk of dementia and alzheimer disease.
Arch Neurol, 62 (2005), pp. 1556-1560
[8.]
E.P. Helzner, J.A. Luchsinger, N. Scarmeas, S. Cosentino, A.M. Brickman, M.M. Glymour, et al.
Contribution of vascular risk factors to the progression in alzheimer disease.
Arch Neurol, 66 (2009), pp. 343-348
[9.]
M.M. Breteler, J.C. Van Swieten, M.L. Bots, D.E. Grobbee, J.J. Claus, J.H. Van den Hout, et al.
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam study.
Neurology, 44 (1994), pp. 1246-1252
[10.]
A. Verdelho, S. Madureira, J.M. Ferro, A.M. Basile, H. Chabriat, T. Erkinjuntti, et al.
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. the LADIS study.
J Neurol Neurosurg Psychiatry, 78 (2007), pp. 1325-1330
[11.]
F.M. Gunning-Dixon, A.M. Brickman, J.C. Cheng, G.S. Alexopoulos.
Aging of cerebral white matter: A review of MRI findings.
Int J Geriatr Psychiatry, 24 (2009), pp. 109-117
[12.]
B. Segura, M.A. Jurado, N. Freixenet, C. Falcón, C. Junqué, A. Arboix.
Microstructural white matter changes in metabolic syndrome patients: A diffusion tensor imaging study.
Neurology, 73 (2009), pp. 438-444
[13.]
A. Kearney-Schwartz, P. Rossignol, S. Bracard, J. Felblinger, R. Fay, J.M. Boivin, et al.
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints.
Stroke, 40 (2009), pp. 1229-1236
[14.]
M.J. Medrano, E. Cerrato, R. Boix, M. Delgado-Rodriguez.
Cardiovascular risk factors in spanish population: Metaanalysis of cross-sectional studies.
Med Clin (Barc), 124 (2005), pp. 606-612
[15.]
J.L. Del Barrio, M.J. Medrano, A. Arce, A. Bergareche, F. Bermejo, J. Diaz, et al.
Prevalence of vascular risk factors among spanish populations aged 70 years and over, as reported in door-to-door studies on neurological diseases.
Neurologia, 22 (2007), pp. 138-146
[16.]
M. Grau, I. Subirana, R. Elosua, P. Solanas, R. Ramos, R. Masia, et al.
Trends in cardiovascular risk factor prevalence (1995–2000–2005) in northeastern spain.
Eur J Cardiovasc Prev Rehabil, 14 (2007), pp. 653-659
[17.]
J. Marrugat, A. Arboix, L. Garcia-Eroles, T. Salas, J. Vila, C. Castell, et al.
The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia.
Rev Esp Cardiol, 60 (2007), pp. 573-580
[18.]
M.T. Alzamora, M. Sorribes, A. Heras, N. Vila, M. Vicheto, R. Fores, et al.
Ischemic stroke incidence in santa coloma de gramenet (ISISCOG), spain. A community-based study.
BMC Neurol, 8 (2008), pp. 5
[19.]
P.C. Van den Hoogen, J.C. Seidell, A. Menotti, D. Kromhout.
Blood pressure and long-term coronary heart disease mortality in the seven countries study: Implications for clinical practice and public health.
Eur Heart J, 21 (2000), pp. 1639-1642
[20.]
R.B.S. D’Agostino, S. Grundy, L.M. Sullivan, P. Wilson, CHD Risk Prediction Group.
Validation of the framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation.
JAMA, 286 (2001), pp. 180-187
[21.]
J. Ferrieres.
The french paradox: Lessons for other countries.
Heart, 90 (2004), pp. 107-111
[22.]
R. Masia, A. Pena, J. Marrugat, J. Sala, J. Vila, M. Pavesi, et al.
High prevalence of cardiovascular risk factors in gerona, spain, a province with low myocardial infarction incidence. REGICOR investigators.
J Epidemiol Community Health, 52 (1998), pp. 707-715
[23.]
O. Lao, I. Dupanloup, G. Barbujani, J. Bertranpetit, F. Calafell.
The mediterranean paradox for susceptibility factors in coronary heart disease extends to genetics.
Ann Hum Genet, 72 (2008), pp. 48-56
[24.]
N. Scarmeas, Y. Stern, R. Mayeux, J.A. Luchsinger.
Mediterranean diet, alzheimer disease, and vascular mediation.
Arch Neurol, 63 (2006), pp. 1709-1717
[25.]
N. Scarmeas, Y. Stern, R. Mayeux, J.J. Manly, N. Schupf, J.A. Luchsinger.
Mediterranean diet and mild cognitive impairment.
Arch Neurol, 66 (2009), pp. 216-225
[26.]
M.T. Alzamora, J.M. Baena-Diez, M. Sorribes, R. Fores, P. Toran, M. Vicheto, et al.
Peripheral arterial disease study (PERART): Prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality.
BMC Public Health, 7 (2007), pp. 348
[27.]
WAIS-III.
Escala de inteligencia weshcler para adultos-III; adaptación española.
Tea ediciones, (1999),
[28.]
M.F. Folstein, S.E. Folstein, P.R. McHugh.
Mini-mental state. A practical method for grading the cognitive state of patients for the clinician.
J Psychiatr Res, 12 (1975), pp. 189
[29.]
M.D. Lezak.
Neuropsychological assessment.
4ª, Oxford University Press, (2004),
[30.]
J. Marrugat, R. D’Agostino, L. Sullivan, R. Elosua, P. Wilson, J. Ordovas, et al.
An adaptation of the framingham coronary heart disease risk function to european mediterranean areas.
J Epidemiol Community Health, 57 (2003), pp. 634-638
[31.]
J. Marrugat, I. Subirana, E. Comin, C. Cabezas, J. Vila, R. Elosua, et al.
Validity of an adaptation of the framingham cardiovascular risk function: The VERIFICA study.
J Epidemiol Community Health, 61 (2007), pp. 40-47
[32.]
P.W. Wilson, R.B. D’Agostino, D. Levy, A.M. Belanger, H. Silbershatz, W.B. Kannel.
Prediction of coronary heart disease using risk factor categories.
Circulation, 97 (1998), pp. 1837-1847
[33.]
S.M. Grundy, J.I. Cleeman, S.R. Daniels, American Heart Association, National Heart, Lung, and Blood Institue, et al.
Diagnosis and management of the metabolic syndrome. An american heart Association/National heart, lung, and blood institute scientific statement. executive summary.
Cardiol Rev, 13 (2005), pp. 322-327
[34.]
A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, et al.
Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure.
Hypertension, 42 (2003), pp. 1206-1252
[35.]
Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults.
Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III).
JAMA, 285 (2001), pp. 2486-2497
[36.]
R.K. Heaton.
WCST-64: Computer version 2- research edition.
Psychological Assessment Resources, (2005),
[37.]
C.J. Golden.
Stroop. Test de Colores y Palabras.
TEA ediciones, (1994),
[38.]
C.K. Conners.
Conners’ continuous performance test.
Multi-Health Systems, (1995),
[39.]
WMS-III.
Escala de memoria weschler-III. adaptación española.
TEA ediciones, (2004),
[40.]
Grooved pegboard test user instructions. Lafayette Instrument; 2002. falta ciudad.
[41.]
D. Knopman, L.L. Boland, T. Mosley, G. Howard, D. Liao, M. Szklo, et al.
Cardiovascular risk factors and cognitive decline in middle-aged adults.
Neurology, 56 (2001), pp. 42-48
[42.]
V.N. Pavlik, D.J. Hyman, R. Doody.
Cardiovascular risk factors and cognitive function in adults 30–59 years of age (NHANES III).
Neuroepidemiology, 24 (2005), pp. 42-50
[43.]
B. Segura, M.A. Jurado, N. Freixenet, C. Albuin, J. Muniesa, C. Junque.
Mental slowness and executive dysfunctions in patients with metabolic syndrome.
Neurosci Lett, 462 (2009), pp. 49-53
[44.]
M.W. Vernooij, M.A. Ikram, H.A. Vrooman, P.A. Wielopolski, G.P. Krestin, A. Hofman, et al.
White matter microstructural integrity and cognitive function in a general elderly population.
Arch Gen Psychiatry, 66 (2009), pp. 545-553
[45.]
S. Black, F. Gao, J. Bilbao.
Understanding white matter disease: Imaging-pathological correlations in vascular cognitive impairment.
[46.]
C. Iadecola, L. Park, C. Capone.
Threats to the mind: Aging, amyloid, and hypertension.
[47.]
F. Rigo Carratala, G. Frontera Juan, J. Llobera Canaves, T. Rodriguez Ruiz, I. Borras Bosch, E. Fuentespina Vidal.
Prevalence of cardiovascular risk factors in the balearic islands (CORSAIB study).
Rev Esp Cardiol, 58 (2005), pp. 1411-1419
[48.]
V. Gil-Guillen, D. Orozco-Beltran, A. Maiques-Galan, J. Aznar-Vicente, J. Navarro, L. Cea-Calvo, et al.
Agreement between REGICOR and SCORE scales in identifying high cardiovascular risk in the Spanish population.
Rev Esp Cardiol, 60 (2007), pp. 1042-1050
[49.]
J.L. Taberner, D. Forés, J. Ribot, R.M. Riera, C. Cabezas, C. Castell, et al.
Consens sobre les activitats preventives a l’edat adulta dins l’atenció primària: llibre blanc.
Direcció General de Salut Pública, 2.ª, Direcció General de Salut Pública, (2006),
Copyright © 2010. Sociedad Española de Neurología
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos